17366-48-2

Basic information

• Product Name: Exo-3-hydroxy-8-azabicyclo[3.2.1]octane hydrochloride
• Synonyms: Exo-3-hydroxy-8-azabicyclo[3.2.1]octane hydrochloride;Exo-3-hydroxy-8-azabicycl...;exo-8-Azabicyclo[3.2.1]octan-3-ol hydrochloride;(3-exo)-8-Azabicyclo[3.2.1]octan-3-ol hydrochloride;EXO-3-HYDROXY-8-AZABICYCLO[3.2.1]OCTANE HCL
• CAS NO: 17366-48-2
• Molecular Formula: C₇H₁₃NO*ClH
• Molecular Weight: 163.64516
• Mol File: 17366-48-2.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: Exo-3-hydroxy-8-azabicyclo[3.2.1]octane hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: Exo-3-hydroxy-8-azabicyclo[3.2.1]octane hydrochloride(17366-48-2)
• EPA Substance Registry System: Exo-3-hydroxy-8-azabicyclo[3.2.1]octane hydrochloride(17366-48-2)

Safety Data

• Hazardous Substances Data: 17366-48-2(Hazardous Substances Data)

Usage

General Description

Exo-3-hydroxy-8-azabicyclo[3.2.1]octane hydrochloride is a chemical compound that is commonly used as a pharmaceutical agent. It is a hydrochloride salt of Exo-3-hydroxy-8-azabicyclo[3.2.1]octane, and belongs to the class of bicyclic compounds. This chemical is known to have psychoactive effects and is used for its potential in treating disorders such as depression, anxiety, and substance abuse. It acts on the central nervous system by modulating the levels of certain neurotransmitters, and is under investigation for its potential therapeutic applications in various neuropsychiatric conditions. Additionally, it may also have potential uses in research and development of new drugs for neurological and psychiatric disorders.

Upstream product

• 135-97-7 pseudotropine 
• 28957-72-4 N-benzylnortropinone 
• 185099-67-6 N-Boc-nortropinone 
• 194222-05-4 (1R,3R,5S)-tert-butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate 

Downstream Products

• 1430741-50-6 (1R,3S,5S)-8-(4-iodophenyl)-8-azabicyclo[3.2.1]octan-3-ol 
• 1430741-52-8 (1R,3S,5S)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-8-azabicyclo[3.2.1]octan-3-ol 
• 1032888-16-6 exo-8-[1-(diphenylmethyl)azetidin-3-yl]-8-azabicyclo[3.2.1]octan-3-ol 

Relevant articles and documents

NOVEL PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

The invention relates to PI3K inhibitors of the formula (I) ? in which all of the variables are as defined in the specification, to their preparation, to their medical use, in particular to their use in the treatment of cancer and neurodegenerative disorders, and to medicaments comprising them.

Phthalazine derivatives and remedies for erectile dysfunction

The present invention provides a phthalazine compound as a therapeutic agent for erectile dysfunction represented by the following formula, a pharmacologically acceptable salt thereof or a hydrate thereof: wherein R1and R2are the same as or different from each other and represent a halogen atom, a C1 to C4 alkyl group which may be substituted with a halogen atom, a C1 to C4 alkoxy group which may be substituted with a halogen atom or a cyano group; X represents a cyano group, a nitro group, a halogen atom, a hydroxyimino group which may be substituted or a heteroaryl group which may be substituted; Y represents a heteroaryl group, an aryl group which may be substituted, an alkynyl group which may substituted, an alkenyl group, an alkyl group, an optionally substituted saturated or unsaturated 4- to 8-membered amine ring, and the cyclic amine compound is a monocyclic compound, bicyclic compound or a spiro compound; l is an integer of 1 to 3; provided that the case where l is 1 or 2, X is a cyano group, a nitro group or a chlorine atom, R1is a chlorine atom, R2is a methoxy group and Y is a 5- or 6-membered amine ring substituted with a hydroxyl group is excluded.